Article Details
Retrieved on: 2025-08-08 18:31:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
With the acquisition, Accord BioPharma, the US specialty business of Intas, continues the commercialisation of UDENYCA to decrease the incidence of ...
Article found on: indiamedtoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here